| TOP NEWS
The Senate approved President Donald Trump’s pick for his second U.S. Department of Health and Human Services secretary Wednesday, following Democratic complaints about the nominee’s ties to the pharmaceutical industry.
Shire PLC on Tuesday tore into Allergan Inc.’s effort to escape antitrust litigation over its “stranglehold” on Medicare business for dry-eye drugs, accusing Allergan of disingenuously claiming Medicare Part D isn’t a distinct market.
Former USA Gymnastics national team doctor and Michigan State University faculty member Larry Nassar, who pled guilty to multiple sexual abuse charges, was sentenced to 40 to 175 years in prison by a Michigan state judge Wednesday after testimony from more than 150 athletes who say they were abused by him.
Prosecutors on Wednesday asked a federal judge to side with a magistrate judge and let them add more claims to a whistleblower’s allegation that Fresenius Medical Care Holdings Inc. violated the False Claims Act by billing Medicare for unnecessary hepatitis B tests.
The latest successes for McDermott Will & Emery’s health group include handling a set of transactions that put Massachusetts-based Steward Health Care in nine more states and helping an addiction treatment center expand across the country, landing the firm among Law360’s Practice Groups of the Year.
POLICY & REGULATION
Under pressure from a White House that has repeatedly singled out Chicago as a hotbed of violence, the new U.S. attorney for the Northern District of Illinois said Wednesday he will continue the office’s focus on violent crime but won’t let up on its fraud investigations.
The U.S. Food and Drug Administration and the Federal Trade Commission on Wednesday warned companies to stop peddling dietary supplements and other products online with unproven claims that they treat opioid addiction and withdrawal, saying such health fraud scams pose serious health risks.
Massachusetts’ new top federal prosecutor said Wednesday he plans to continue a crackdown on pharmaceutical and biotechnology companies accused of shelling out cash to patient-assistance charities on the condition that the donations be funneled only to patients who buy the donor’s products.
The U.S. Securities and Exchange Commission is investigating the circumstances behind the $15 billion General Electric Co. is adding to reserves for its reinsurance arm after it reassessed the rising cost of claims made under long-term care policies, the company said on Wednesday.
The NCAA said Wednesday it will investigate the Michigan State University athletic department regarding rule violations related to the assaults committed by former school employee and USA Gymnastics doctor Larry Nassar.
California medical device company DJO Global Inc. will pay $7.62 million to settle allegations it submitted false claims for nerve-stimulating electrodes to Tricare, a government health benefit program for military personnel, the U.S. Department of Justice announced Tuesday.
A New Jersey federal judge on Wednesday acquitted U.S. Sen. Bob Menendez, D-N.J., of charges he received political donations as bribes from a Florida eye doctor while upholding charges that the senator accepted private jet rides and other gifts in exchange for his official actions.
The Eleventh Circuit on Wednesday shot down a Florida social worker’s bid to revive her False Claims Act accusations against a nonprofit hospice provider, ruling a lower court was right to dismiss the $320 million whistleblower suit because her claims lacked specific details about the alleged fraud.
Rite Aid Corp. will pay $4 million to end a criminal investigation into its improper sales of pseudoephedrine, the Sudafed ingredient used to make methamphetamine, West Virginia federal prosecutors announced Wednesday.
A Michigan hospital will have the chance to mediate state and federal antitrust claims against it, but the parties must reach a settlement before their March court date or go to trial, a Michigan federal judge said Tuesday, rejecting the hospital’s request for a continuance.
Rite Aid Corp. has been overcharging insured customers for their prescription generic drugs by misreporting how much it charges customers who buy the same drugs without insurance, according to a putative class action filed Tuesday in California federal court.
Illinois-based Camp Drug Stores Inc. won a small victory in Illinois federal court on Wednesday as a federal judge refused to toss a Telephone Consumer Protection Act class action the pharmacy brought against a Florida pharmaceutical company — one of seven junk fax suits Camp Drug has filed in the last two years.
The Federal Circuit on Wednesday upheld a Patent Trial and Appeal Board judgment against Arthrex Inc. in a case over a suture anchor patent, possibly impacting the company’s ability to obtain future patents on the suture products.
The Trump administration’s recent announcement that it will support state efforts to impose work requirements on Medicaid beneficiaries is unconstitutional and improperly bypasses the legislative process, a proposed class of Kentucky residents said in a lawsuit filed Wednesday in D.C. federal court.
A New Jersey federal judge on Tuesday tossed a lawsuit alleging the state discriminates against lesbians seeking insurance coverage for infertility treatments, ruling that the public agencies and individuals named in the suit are shielded by sovereign immunity.
Allergan and Warner Chilcott on Tuesday asked a Massachusetts federal court for an order stating that lists of prescription drugs covered by insurers are admissible evidence during an antitrust trial brought by a class of organizations that purchased ulcerative colitis drug Asacol.
A federal judge in New York on Tuesday dismissed a shareholder suit against Express Scripts claiming company officials misled investors about the pharmacy benefit managers’ rocky partnership with Anthem Inc., saying the shareholders failed to meet federal requirements for a derivative action.
Alberta, Canada-based Aurora Cannabis Inc. struck a CA$1.1 billion ($890 million) cash-and-stock deal to snap up rival CanniMed Therapeutics Inc., the pair announced Wednesday, ending a monthslong takeover fight between the medical cannabis companies.
Expect to see antitrust developments in 10 areas this year, including continuing scrutiny of vertical mergers, no-poach agreements and conduct by pharmaceutical companies, say attorneys with Cooley LLP.
New tools make it easier for law firms to develop their own technology, but many firms are struggling with the question of whether doing so is best for them. Here, the first in a two-part series looking at BigLaw’s build versus buy dilemma.
Goodwin Procter LLP announced in a memo made public Wednesday that the vast majority of its associates would receive year-end bonuses on par with or exceeding the familiar scale established by Cravath Swaine & Moore LLP, which has remained the standard for several BigLaw firms.
Bar exam prep company BarBri and three blind law students who had alleged the company failed to provide equal access to parts of its courses in violation of the Americans with Disabilities Act have settled the dispute, according to court documents filed this week.
Senate Democrats on Wednesday bitterly complained about their GOP colleagues’ advancement of President Donald Trump’s choice for a Seventh Circuit vacancy, accusing the Senate Judiciary Committee chair of tearing down a tradition that allows minority senators to influence the confirmation process.
We hope you found this message to be useful.
However, if you’d rather not receive future emails of this sort,
you may unsubscribe here.
Please DO NOT reply to this email. For customer support inquiries, please call 1-646-783-7100 or visit our Contact Us page.
Law360 | Portfolio Media, Inc, 111 West 19th Street, 5th Floor, New York, NY 10011